Safety of an extended-release injectable moxidectin suspension formulation (ProHeart ® 12) in dogs

The safety of ProHeart ® 12 (PH 12; extended-release injectable suspension; 10% moxidectin in glyceryl tristearate microspheres) was evaluated in four studies using Beagle dogs and one study using ivermectin-se...

Source: Parasites and Vectors - September 6, 2019 Category: Microbiology Authors: Matthew J. Krautmann, Sean Mahabir, Ann Fielder, Wendy Collard, Tracie L. Wolthuis, Kevin Esch, Tracy Morton, Kent Alleman, Laibin Luo, Erin McCandless, Steven Nederveld, Kristina Kryda, Ryan Carroll and Joseph F. Boucher Tags: Research Source Type: research